Brief: Cabaletta Bio Reports Q4, Full Year 2021 Financial Results
17/03/2022 11:09
March 17 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CABALETTA BIO INC - ENDED 2021 WITH $122.2 MILLION IN CASH
ON
HAND TO FUND OPERATIONS THROUGH 3Q 2023
* CABALETTA BIO INC QTRLY NET LOSS PER VOTING AND NON-VOTING
SHARE, BASIC AND DILUTED $0.49
Source text for Eikon: ID:nGNX1DPlJy
Further company coverage: CABA.O
Recent news on Cabaletta Bio
See all newsBrief: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cabaletta Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cabaletta Bio Q2 net loss widens as R&D costs rise
Cabaletta Bio, Inc. expected to post a loss of 37 cents a share - Earnings Preview
Cabaletta Bio Inc expected to post a loss of 37 cents a share - Earnings Preview